REVIEW ON SWERTIA CHIRATA AS TRADITIONAL USES TO ITS PYHTOCHEMISTRY AND PHRMACOLOGICAL ACTIVITY
Swertia chirata (Gentianaceae), is a popular medicinal plant native to temperate Himalaya. The plant of Swertia chirata is found at an altitude of 1200-1300m, from Bhutan to Kashmir and in the Khasi hills at 1200-1500m. It also can be grown in sub-temperate territories between 1500-2100m altitudes. Chirata has an erect and about 2-3 ft long stem. Herbal medicinal plants are necessary for about for about 80% of the world population in developed and developing countries for their basic and primary health care required owing to better tolerability, superior empathy with human body and having lesser side effects. Herbal plants are considered as rich source of phytochemical ingredients. The main chemical ingredients are Swertiamarin, Amarogentin, Swechirin, Mangiferin, Sweroside, Gentianine, Amaroswerin, Oleanolic acid, Swertanoone, Ursolic acid. Phytochemical analysis divulges alkaloids, flavonoids, steroids, glycosides, triterpenoids, saponins, xanthones and ascorbic acid in all samples. Nepali S. chirata was found to have finest TLC (thin layer chromatography). People have been using traditional medicinal plants for thousand years ago. Traditional plants play a very important role in preventing and treating of human diseases. Medicinal usage of Swertia chirata is reported in Indian pharmaceutical codex, the American and the British pharmacopoeias and in the different traditional systems of medicine (Unani, Ayurveda and Siddha). Swertia chirata is commonly known as a bitter tonic in traditional system of medicine for the treatment of fever, loss of appetite, digestive disorders, diabetes, skin and various other diseases.
Keywords: Swertia chirata, swerchirin, Anti-inflammatory, Oleanolic acid, Traditional medicine.
2. Sewell Robert DE, and Mahmoud Rafieian Kopaei. “The history and ups and downs of herbal medicine usage.” Journal of Herbmed Pharmacology 2014; 3(1):1-3.
3. Kumar V. and Van Staden J., A review of Swertia chirayita (Gentianaceae) as a traditional medicinal plant. Frontiers in pharmacology, 2016; 6:308.
4. Bentley R. and Trimen H (1880) “Medicinal Plant” J and A Churchill: London, pp.183.
5. Clarke C. B. Verbenaceae, in The Flora of British India, Vol. IV, ed Hooker J. D., editor. (London: L. Reeve and Co), 1885; pp.560–604.
6. Gaur R.D., 1999. Flora of the District Garhwal North West Himalaya: With Ethnobotanical Notes. Trans Media Publication, Srinagar Garhwal, India, pp. 811.
7. Scartezzini P., and Speroni E. Review on some plants of Indian Traditional Medicine with Antioxidant Activity. J.Ethnopharmacol. 2000; 71:23–42. doi: 10.1016/S0378-8741 (00) 00213-0.
8. Kirtikar,K. R. and Basu, B. D. (eds) “Indian Medicinal Plants”, Allahabad, 1984; vol. III, pp. 1664–1666.
9. Laxmi A., Siddhartha S. and Archana M., Antimicrobial screening of methanol and aqueous extracts of Swertia chirata. Int J Pharm Pharm Sci, 2011; 3(4):142-146.
10. Tabassum S., Mahmood S., Hanif J., Hina M. and Uzair B. An overview of medicinal importance of Swertia chirayita. International Journal of Applied, 2012; 2(1).
11. Mahmood S., Hussain S., Tabassum S., Malik F. and Riaz H., Comparative phytochemical, hepatoprotective and antioxidant activities of various samples of Swertia Chirayita collected from various cities of Pakistan. Pak. J. Pharm. Sci, 2014; 27(6):1975-1983.
12. Saha P., Mandal S., Das A., Das P.C. and Das S., Evaluation of the anti-carcinogenic activity of Swertia chirata Buch. Ham, an Indian medicinal plant, on DMBA‐induced mouse skin carcinogenesis model. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 2004; 18(5):373-378.
13. Alam K.D., Ali, M.S., Parvin S., Mahjabeen S., Akbar M.A. and Ahamed R. In vitro antimicrobial activities of different fractions of Swertia chirata ethanolic extract. Pakistan journal of biological sciences: PJBS, 2009; 12(19):1334-1337.
14. Sultana, M.J. and Ahmed, F.R.S., Phytochemical investigations of the medicinal plant Swertia chirata Ham. Biochem Anal Biochem, 2013; 2(145):2161-1009.
15. Hussain S, Malik F, Khalid N, Qayyum MA and Riaz H, Alternative and traditional medicines systems in Pakistan: History, Regulation, Trends, Usefulness, Challenges, Prospects and Limitations, A Compendium of Essays on Alternative Therapy, Arup Bhattacharya (Ed.), ISBN: 978-953-307-863-2. 1st ed. In Tech., 2012; pp. 89-108.
16. World Health organization (2000). Hepatitis B (Fact sheet No. 204). Geneva, Switzerland.
17. Ambasta S. P. (Ed). (1986). The Useful Plants of India. PID, CSIR, New Delhi.
18. Khanal S. et al, Swertia chirata The Himalayan Herb. International journal of applied science and biotechnology 2014; 2(4):389-392
19. Joshi P. and Dhawan, V., 2005. Swertia chirayita–an overview. Current science, pp.635-640.
20. Kirtiker K. B. (1996). Indian Medicinal Plants (2 ed., Vol. 3). Dehradun: International Book Distributors, Rajpur road, Dehradun, India.pp.1664-66
21. Anonymous, The Unani Pharmacopoeia Of India, CCRUM, Department of AYUSH Ministry of Health & Family Welfare, Government of India Rakmo Press New Delhi - 110 020, 2007.
22. Chopra R. N. (1956). Glossary of Indian Medicinal Plants. New Delhi: Councel of Scientific and Industrial Research.pp. 237
23. Nadkarni A. K. (1989). Indian Materia Medica. Bombay: Bombay Popular Prakashan.pp. 1184-1185
24. Anonymous (1992), The Unani Pharmacopoeia Of India, CCRUM, (Vol. 2) Department of AYUSH Ministry of Health & Family Welfare, Government of India Seema Offset Press New Delhi-110006. pp.117-125
25. Kumar N. et al, Review on Swertia Chirata Buch.-Ham. Ex Wall: A Bitter Herb W.S.R. to Its Phytochemistry and Biological Activity. International Ayurvedic medical journal, 2017; 5(9).
26. Baitar I. e. (2000). Al Jame- Al- Mufrada- Al Advia Wa Al- Aghzia(Urdu translation). CCRUM, New Delhi; Vol-II. New Delhi: CCRUM.
27. Negi J.S., Singh, P. and Rawat, B. Chemical constituents and biological importance of Swertia: a review. Curr Res Chem, 2011; 3(1):1-15.
28. Ibn-e-Sina (2007). Alqanoon fil tibb(Urdu Translation by HKm Ghulam Hussain Kantoori). Delhi: Aijaz Publishing House.
29. Hakeem H. M. (YNM). Bustan ul Mufradat. Lucknow: Idara Traraqqi Urdu Publications.
30. Anonymous. (2006). The Unani Pharmacopoea of India (Vol. V). Delhi: Department of AYUSH, Ministry of Health and Family Welfare, Government of India.
31. Anonymous. (YNM) “Standardisation of Single Drugs of Unani Medicine” (Vol.III). New Delhi: CCRUM Department of AYUSH Ministry Of Health And Family Welfare, Government of India.
32. Hakeem Mohammad Abdul Hakeem, Bustan Ul Mufredat, Idara Kitab-ul-Shifa Dariya Ghanj Delhi 2011; 110002, 2002; pp.142.
33. Kabiruddin H.,(YNM) Makhzan Ul Mufredat, Aijaz Publishing House Dariya Ganj New Delhi.
34. Nag G., Das S., Das S., Mandal S. and De B. Antioxidant, anti- acetylcholinesterase and anti-glycosidase properties of three species of Swertia, their Xanthones and Amarogentin: A Comparative Study. Pharmacognosy Journal, 2015; 7(2).
35. Saxena A.M., Bajpai M.B.,and Mukherjee S.K. Swerchirin induced blood sugar lowering of streptozotocin treated hyperglycemic rats. Indian J. Exp.Biol. 1991; 29:674–675.
36. Saxena A.M., Bajpai M.B., Murthy P.S., and Mukherjee S.K. Mechanism of blood sugar lowering by a Swerchirin containing hexane fraction (SWI) of Swertia chirayita. Indian J. Exp. Biol. 1993; 31:178–181.
37. Balaraju K., Saravanan S., Agastian P., and Ignacimuthu S. Arapid system for micropropagation of Swertia chirata Buch.-Ham. ex Wall.: an endangered medicinal herb via direct somatic embryogenesis. ActaPhysiol. Plant. 2011; 33:1123-1133. doi:10.1007/s11738-010-0640-5
38. Brahmachari G., S. Mondal A. Gangopadhyay D. Gorai, B. Mukhopadhyay S. Saha and A.K. Brahmachari. Swertia (Gentianaceae): Chemical and pharmacological aspects. Chem. Biodivers., 2004; 1:1627-1651.
39. Ray S., Majumder H.K., Chakravarty, A.K., Mukhopadhyay S., Gil R.R. and Cordell G.A. Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani. Journal of natural products, 1996; 59(1):27-29.
40. Wiart, C., Kumar, K., Yusof, M.Y., Hamimah, H., Fauzi, Z.M., Sulaiman, M. Antiviral properties of ent-labdene diterpenes of Andrographis paniculata nees, inhibitors of herpes simplex virus type 1. Phytother. Res. 2005; 19:1069–1070.
41. Medda S., Mukhopadhyay S., Basu M. K. (1999). Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms. J. Antimicrob. Chemother. 44, 791–794. 10.1093/jac/44.6.791
42. Rafatullah S, Tariq M, Mossa JS, Al-Yahya MA, Al-Said MS, Ageel AM. Protective effect of Swertia chirata against indomethacin and other ulcerogenic agent-induced gastric ulcers. Drugs under experimental and clinical research. 1993; 19(2):69-73.
43. Saha P., Mandal S., Das A., Das S. Amarogentin can reduce hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in mouse skin carcinogenesis model. Cancer Lett. 2006; 244:252–259. 10.1016/j.canlet.2005.12.036
44. Arya R., Sharma S.K., Singh S. Antidiabetic effect of whole plant extract and fractions of Swertia chirayita Buch.-Ham. Plant a Med. 2011; 77:138.doi: 10.1055/s-0031-1273667
45. Chen Y., Huang B., He J., Han L., Zhan Y., Wang Y. In vitro and in vivo antioxidant effects of the ethanolic extract of Swertia chirayita. J. Ethnopharmacol. 2011; 136:309–315.
46. Iqbal Z., Lateef M., Khan M. N., Jabbar A., Akhtar M. S. Anthelmintic activity of Swertia chirata against gastrointestinal nematodes of sheep. Fitoterapia 2006; 77:463–465.10.1016/j.fitote.2006.05.010
47. Kweera B., Sharma N., Jadon V., Negi Y. and Parcha V., Phytochemical analysis and in vitro antibacterial activity of Swertia chirayta whole plant in different solvents. Journal of Pharmacy Research, 2011; 4(12):4448-4449.
48. Ahirwal L., Singh S., Dubey M.K., Bharti V. and Mehta A. Investigation of Antioxidant Potential of Methanolic Extract of Swertia chirata Buch. Ham. European Journal of Medicinal Plants, 2014; 4(11):1345.
49. Bhargava S., Rao P., Bhargava P., Shukla S. Antipyretic potentialof Swertiachirata BuchHam. Sci.Pharm. 2009; 77:617–623.doi: 10.3797/scipharm.0812-10
50. Kumar IV, Paul BN, Asthana R, Saxena A, Mehrotra S, et al. Swertia chirayita mediated modulation of interleukin-1beta, interleukin-6, interleukin-10, interferon-gamma, and tumor necrosis factoralpha in arthritic mice. Immunopharmacol Immunotoxicol 2003; 25:573–583.
51. Joshi P., Dhawan V. Swertia chirayita—an overview. Curr. Sci. 2005; 89:635–640.
52. Mishra K., Dash A.P., Swain Bijay.K., Dey N. Anti-malarial activities of Andrographis paniculata and Hedyotis corymbosa extracts and their combination with curcumin. Malaria J. 2009; 8:26–34.
53. Reen R.K., Karan M., Singh K., Karan V., Johri R.K. and Singh J. Screening of various Swertia species extracts in primary monolayer cultures of rat hepatocytes against carbon tetrachloride-and paracetamol-induced toxicity. Journal of ethnopharmacology, 2001; 75(2-3):239-247.
54. Gupta S., Choudhry M.A., Yadava J.N.S., Srivastava V., Tandon J.S. Antidiarrhoeal activity of diterpenes of Andrographis paniculata (Kal-Megh) against Escherichia coli enterotoxin in in vivo models. Pharm. Biol. 1990; 28:273–283.
55. Nagalekshmi R., Menon A., Chandrasekharan D. K., Nair C. K. K. Hepatoprotective activity of Andrographis paniculata and Swertia chirayita. Food Chem. Toxicol. 2011; 49:3367–3373. 10.1016/j.fct.2011.09.026
56. Kumar V & Van Staden J; A Review of Swertia chirayita (Gentianaceae) as a Traditional Medicinal Plant; PMC, 2015; 6, PMC4709473.
57. Sankar A.S.S., Sugathan N. V. and Mohan M. A REVIEW ON SYNERGISTIC AND HORMETIC ACTION OF SWERTIA CHIRATA FROM HOMOEOPATHIC PERSPECTIVE. International Journal of AYUSH Medicine & Research, 2017; : 2456-6209.
58. Abdul Latif and Sumbul Rehman, Shamim Ahmad and Asad U Khan. In vitro antibacterial screening of the extracts of Sweria chirayita Linn. against MRSA (Methicillin Resistant Staphylococcus aureus). Int J Curr Res Rev, 2011; 3(6):98-104.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).